These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27427125)

  • 21. Pulmonary dysfunction in thalassaemia major: is there any relationship with body iron stores?
    Guidotti F; Piatti G; Marcon A; Cassinerio E; Giuditta M; Roghi A; Fasano V; Consonni D; Cappellini MD
    Br J Haematol; 2017 Jan; 176(2):309-314. PubMed ID: 27766631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low Iron Stores in Otherwise Healthy Children Affect Electrocardiographic Markers of Important Cardiac Events.
    Karadeniz C; Özdemir R; Demirol M; Katipoğlu N; Yozgat Y; Meşe T; Ünal N
    Pediatr Cardiol; 2017 Jun; 38(5):909-914. PubMed ID: 28271153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue Doppler echocardiography reliably reflects severity of iron overload in pediatric patients with beta thalassemia.
    Silvilairat S; Sittiwangkul R; Pongprot Y; Charoenkwan P; Phornphutkul C
    Eur J Echocardiogr; 2008 May; 9(3):368-72. PubMed ID: 17689292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy.
    Chirico V; Lacquaniti A; Salpietro V; Luca N; Ferraù V; Piraino B; Rigoli L; Salpietro C; Arrigo T
    Eur J Endocrinol; 2013 Dec; 169(6):785-93. PubMed ID: 24014554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major.
    Dimitriadou M; Christoforidis A; Economou M; Tsatra I; Vlachaki E; Fidani L; Katzos G; Athanassiou-Metaxa M
    Eur J Haematol; 2010 Jan; 84(1):64-71. PubMed ID: 19744128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidant micronutrients in children with thalassaemia in Egypt.
    Nasr MR; Ali S; Shaker M; Elgabry E
    East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
    Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
    Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate variability in β-thalassaemia major with or without cardiac siderosis.
    Alp A; Ozdogan O; Guloglu CC; Turker M; Atabay B
    Cardiol Young; 2014 Apr; 24(2):263-7. PubMed ID: 23402458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.
    Al-Khabori M; Bhandari S; Al-Rasadi K; Mevada S; Al-Dhuhli H; Al-Kemyani N; Daar S
    Hemoglobin; 2014; 38(5):365-8. PubMed ID: 25074643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of carotid artery dynamics & correlation with cardiac & hepatic iron in β-thalassaemia patients.
    Merchant RH; Chate S; Ahmed J; Ahmad N; Karnik A; Jankaria B
    Indian J Med Res; 2016 Apr; 143(4):443-8. PubMed ID: 27377500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac iron measurement and iron chelation therapy in patients with β thalassaemia major: experience from Taiwan.
    Lu MY; Peng SS; Chang HH; Yang YL; Chen CA; Jou ST; Lin DT; Lin KH
    Transfus Med; 2013 Apr; 23(2):100-7. PubMed ID: 23448138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
    Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
    Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The corrected QT interval prolongation in adolescents with cardiac iron overload β-thalassemia major.
    Advani N; Advani N; Andriastuti M
    Turk J Pediatr; 2020; 62(2):267-273. PubMed ID: 32419419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic consequences of cardiac iron overload in thalassemia major.
    Detterich J; Noetzli L; Dorey F; Bar-Cohen Y; Harmatz P; Coates T; Wood J
    Am J Hematol; 2012 Feb; 87(2):139-44. PubMed ID: 22052662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
    Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
    Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of HCV infection on hepatic fibrosis in patients of thalassaemia major.
    Anwar M; Nadeem A; Jamal S; Dilawar M; Ali W; Aziz S; Ayyub M; Ahmed P; Ashraf T; Khan B; Hussain T; Hussain S;
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):200-3. PubMed ID: 16542600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.